5.29  -0.32 (-5.7%)		06-17 16:00
Open: 5.54 High: 5.555 Volume: 228,677		Pre. Close: 5.61 Low: 5.24 Market Cap: 9(M)

Short term
Mid term
Targets	6-month :	6.49	1-year :	7.14
Resists	First :	5.56	Second :	6.11
Pivot price	5.52
Supports	First :	4.67	Second :	3.88
MAs	MA(5) :	5.61	MA(20) :	5.41
	MA(100) :	6.26	MA(250) :	7.24
MACD	MACD :	0.1	Signal :	0
%K %D	K(14,3) :	46.6	D(3) :	60.7
RSI	RSI(14): 46.3
52-week	High :	10.61	Low :	3.61

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ PILL ] has closed above bottom band by 27.0%. Bollinger Bands are 32.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	5.57 - 5.6	5.6 - 5.63
Low:	5.15 - 5.19	5.19 - 5.22
Close:	5.23 - 5.29	5.29 - 5.34

The fund invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or to ETFs that track the index. The index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. The fund is non-diversified.

Mon, 16 Jun 2025
(PILL) Technical Data - news.stocktradersdaily.com

Tue, 20 May 2025
5 Small-cap Biotech ETFs to Watch - Investing News Network

Mon, 19 May 2025
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion - CVS Health (NYSE:CVS), Cigna Group (NYSE:CI) - Benzinga

Wed, 14 May 2025
Long Term Trading Analysis for (PILL) - news.stocktradersdaily.com

Mon, 12 May 2025
ETFs on the Move Post U.S.-China Trade Deal - Nasdaq

Fri, 11 Apr 2025
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies - Benzinga

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: AMEX
Sector: Financial Services
Industry: Asset Management
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.